Charlotte, North Carolina–(Newsfile Corp. – August 25, 2023) – The Pet Innovation Awards has introduced that cbdMD, Inc. (NYSE American: YCBD), a extremely trusted and acknowledged cannabidiol (CBD) model, and its pet merchandise model, Paw CBD, have been honored with the celebrated “Dog Hip & Joint Product of the Year” award for his or her Hip+Joint Soft Chews within the 2023 awards program.
Paw CBD’s Hip+Joint Soft Chews present important consolation and look after dogs, supporting mobility and enhancing general wellbeing. These useful delicate chews are formulated with confirmed components together with Glucosamine HCL and Chondroitin Sulfate to advertise mobility and Omega-3 Fatty Acids to ease irritation.
Certified by the National Animal Supplement Council (NASC), Paw CBD’s Hip+Joint Chews are available in a tasty bacon taste, making them ultimate for dogs with small, getting old, or delicate enamel. The three available strengths (150 mg, 300 mg, and 600 mg) supply exact serving choices for optimum effectiveness.
Crafted with the corporate’s clinically studied Superior Broad-Spectrum method and premium US-grown hemp, Paw CBD’s Hip+Joint Soft Chews are rigorously third-party lab examined to make sure purity. These veterinarian-formulated chews are THC-free and free from pointless fillers or synthetic components.
“We’re honored to obtain the ‘Dog Hip & Joint Product of the Year’ award from Pet Innovation. Our Hip+Joint Soft Chews had been designed to boost the lives of dogs in want of mobility assist,” said Ronan Kennedy, interim CEO of cbdMD. “This recognition additional strengthens our dedication to bettering the well-being of dogs by progressive CBD merchandise.”
The Pet Innovation Awards Program celebrates innovation and excellence throughout numerous classes within the Pet Care business. This 12 months’s program attracted over 2,000 nominations from across the globe, highlighting the importance of Paw CBD’s win.
Travis Grant, Managing Director of Independent Innovation Awards, emphasised the significance of those CBD hip and joint chews, stating, “PawCBD provides a product that makes day-after-day blissful, wholesome, and comfy for pets. Whether it is stiffness or breed-related hip points, these chews present the right assist for any canine’s mobility.”
For extra details about cbdMD and its partnership with the Pet Innovation Awards, please go to cbdmd.com and https://petinnovationawards.com. Engage on social at @cbdmd.usa.
About cbdMD:
cbdMD, Inc. is among the main and most extremely trusted and acknowledged hemp-derived cannabidiol (CBD) manufacturers with a complete line of U.S. produced, THC-free1 CBD merchandise in addition to Full Spectrum and Delta 9 THC merchandise. The cbdMD model presently contains high-quality, premium CBD merchandise together with tinctures, gummies, topicals, capsules, sleep aids and extra. The Company’s Paw CBD model contains formulated pet merchandise together with tinctures, chews and topicals in various strengths. To be taught extra about cbdMD and the entire line of merchandise, please go to www.cbdmd.com, comply with cbdMD on Instagram and Facebook, or go to one of many hundreds of stores that carry cbdMD merchandise.
About Paw CBD:
Paw CBD is a nationally acknowledged pet client CBD model, providing a variety of pet merchandise that mix the properties of CBD oil with flavors like peanut butter, bacon, and turkey. With over 40 pet client merchandise, Paw CBD is among the fastest-growing manufacturers within the pet CBD house. For extra details about Paw CBD’s THC-free pet merchandise, please go to pawcbd.com.
Forward-Looking Statements:
This press launch comprises sure forward-looking statements which might be based mostly upon present expectations and contain sure dangers and uncertainties throughout the that means of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be recognized utilizing phrases reminiscent of ”ought to,” ”might,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”tasks,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements usually are not ensures of future efficiency and are topic to dangers, uncertainties, and different components, a few of that are past our management and troublesome to foretell. You are urged to rigorously assessment and take into account any cautionary statements, together with however not restricted to expectations on our partnership with Dr. Vega, and different disclosures, together with the statements made underneath the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-Okay for the fiscal 12 months ended September 30, 2022 as filed with the Securities and Exchange Commission (the “SEC”) and our different filings with the SEC. All forward-looking statements contain vital dangers and uncertainties that might trigger precise outcomes to vary materially from these within the forward-looking statements, a lot of that are typically exterior the management of cbdMD, Inc. and are troublesome to foretell. cbdMD, Inc. doesn’t undertake any obligation to update any forward-looking statements besides as could also be required by legislation. The data which seems on our web sites and our social media platforms, together with, however not restricted to, Instagram and Facebook, isn’t a part of this press launch.
1 THC-free is outlined as beneath the extent of detection utilizing validated scientific analytical instruments.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, Interim CEO & CFO
+1 (704) 445-3064
[email protected]
